IQVIA Apr 23, 2026 The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags, boosting Novo's shares - Fierce Pharma
FierceBiotech Mar 26, 2026 Biopharma funding dropped 20% in 2025 as companies doubled down on big bets: IQVIA
IQVIA Mar 13, 2026 Expanding Options for Emerging Biopharma in the U.S.: A conversation with Meg Hooton, IQVIA Biotech - IQVIA